| Date | Time | Source | Headline | Symbol | Company |
| 10/07/2021 | 10:09AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 10/06/2021 | 9:43AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 10/06/2021 | 9:42AM | UK Regulatory | Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 10/05/2021 | 12:06PM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 Amend | LSE:0A8E | Xeris Biopharma Inc |
| 10/05/2021 | 10:15AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 10/04/2021 | 8:04AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 10/01/2021 | 10:04AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 10/01/2021 | 5:13AM | UK Regulatory | Morgan Stanley Smith Barney LLC Form 8.3 - XERIS PHARMACEUTICALS INC | LSE:0A8E | Xeris Biopharma Inc |
| 09/30/2021 | 12:07PM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/30/2021 | 9:58AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/30/2021 | 5:22AM | UK Regulatory | Morgan Stanley Smith Barney LLC Form 8.3 - XERIS PHARMACEUTICALS INC | LSE:0A8E | Xeris Biopharma Inc |
| 09/29/2021 | 9:36AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/28/2021 | 9:22AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/28/2021 | 9:21AM | UK Regulatory | Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/28/2021 | 9:19AM | UK Regulatory | Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/27/2021 | 7:27AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/24/2021 | 11:35AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/24/2021 | 8:05AM | UK Regulatory | Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/23/2021 | 9:35AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/23/2021 | 9:18AM | UK Regulatory | Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/23/2021 | 9:18AM | UK Regulatory | Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/22/2021 | 10:00AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/22/2021 | 9:12AM | UK Regulatory | Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/22/2021 | 9:12AM | UK Regulatory | Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/22/2021 | 7:18AM | UK Regulatory | Morgan Stanley Smith Barney LLC Form 8.3 - XERIS PHARMACEUTICALS INC | LSE:0A8E | Xeris Biopharma Inc |
| 09/21/2021 | 10:03AM | UK Regulatory | J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 | LSE:0A8E | Xeris Biopharma Inc |
| 09/21/2021 | 9:17AM | UK Regulatory | Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/21/2021 | 9:16AM | UK Regulatory | Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/21/2021 | 8:39AM | UK Regulatory | Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |
| 09/20/2021 | 8:53AM | UK Regulatory | Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc | LSE:0A8E | Xeris Biopharma Inc |